Prof. Dr. Meinrad Beer, Director of the Clinic for Diagnostic and Interventional Radiology, University Hospital Ulm

Prof. Meinrad Beer

mint Lesion™ has become an indispensable part of our tumor boards and clinical trials. It significantly strengthens the recognition of radiology and the cooperation between imaging departments and with clinical partners.

Related Resources

Related Resources

BioPharma Clinical Trials Nexus

11/18 to 11/19/2025 Parsippany-Troy Hills, NJ

24th BioPharma Clinical Trials Nexus

Interview with Prof. Timm Denecke about the RACOON-MARDER project and AI-powered early detection of liver cancer using MRI

“Making the Invisible Visible”: How RACOON-MARDER Aims to Improve Early Detection of Liver Cancer Using MRI and AI

Hepatocellular carcinoma (HCC) is a potentially deadly tumor. The decisive factor is the timing of diagnosis: if HCC is detected early, there is a…

Image of a patient getting an MRI scan, signifying how RACOON projects in Germany show how imaging, structured reporting, and AI jointly advance clinical research.

RACOON – Imaging, Data & Collaboration for Better Decisions

Modern radiology faces a central question: how can imaging and clinical data be combined in a way that leads to more precise diagnoses,…